IP Library Granted Patent US 8,700,162
Granted Patent B2
US 8,700,162 · App. 13/646,824 · Granted Apr 15, 2014

Devices and methods for treatment of heart failure and associated conditions

Inventors: Dimitrios Georgakopoulos (Maple Grove, MN); Eric Grant Lovett (Mendota Heights, MN)
Assignee: CVRx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,700,162
App. No.
13/646,824
Granted
Apr 15, 2014
Kind
B2
Abstract

Devices and methods of use for identification, treatment and/or management of heart failure and/or associated conditions. An exemplary device may include a first sensor configured to monitor a parameter indicative of a fluid level in a pulmonary circulation of a patient, a second sensor configured to monitor a parameter indicative of a fluid level in a non-pulmonary circulation of a patient, and a control system coupled to the first sensor and second sensor. The control system is configured to provide a baroreflex therapy to the patient based at least in part on the parameter indicative of a fluid level in a pulmonary circulation and the parameter indicative of a fluid level in a non-pulmonary circulation. The baroreflex therapy adjusts at least one of the fluid level in the pulmonary circulation and the fluid level in the non-pulmonary circulation.

Claims (26)

1. A medical device comprising:

a first sensor configured to monitor a parameter indicative of a fluid level in a pulmonary circulation of a patient;

a second sensor configured to monitor a parameter indicative of a fluid level in a non-pulmonary circulation of a patient;

a control system coupled to the first sensor and second sensor, the control system configured to provide a baroreflex therapy to the patient based at least in part on the parameter indicative of a fluid level in a pulmonary circulation and the parameter indicative of a fluid level in a non-pulmonary circulation, wherein the baroreflex therapy adjusts at least one of the fluid level in the pulmonary circulation and the fluid level in the non-pulmonary circulation.

2. The device of claim 1 , wherein the second sensor is configured to monitor a splanchnic measurement representative of fluid status associated with a splanchnic organ.

3. The device of claim 1 , wherein the control system is configured to provide the baroreflex therapy in response to at least one of a decrease in the parameter indicative of a fluid level in the non-pulmonary circulation below a specified threshold value or an increase in the parameter indicative of a fluid level in the pulmonary circulation above a specified threshold value.

4. A method, comprising:

monitoring an indicator of a fluid level in a pulmonary circulation of a patient;

monitoring an indicator of a fluid level in a non-pulmonary circulation of the patient;

delivering a baroreflex therapy based at least in part on the parameter indicative of a fluid level in a pulmonary circulation and the parameter indicative of a fluid level in a non-pulmonary circulation, wherein the baroreflex therapy adjusts at least one of the fluid level in the pulmonary circulation and the fluid level in the non-pulmonary circulation.

5. The method of claim 4 , wherein delivering the baroreflex therapy further comprises delivering the baroreflex therapy in response to a decrease in the indicator of a fluid level in the non-pulmonary circulation of the patient below a specified threshold value.

6. The method of claim 4 , wherein delivering the baroreflex therapy further comprises decreasing or ceasing the baroreflex therapy in response to at least one of:

a change in the indicator of a fluid level in the pulmonary circulation beyond a predetermined threshold value; or

a change in the indicator of a fluid level in the non-pulmonary circulation beyond a predetermined threshold value.

7. A method, comprising:

causing a baroreflex therapy system to be manufactured and made available to a user;

providing instructions recorded on a tangible medium to the user, the instructions comprising:

monitoring an indicator of a fluid level in a pulmonary circulation of the patient;

monitoring an indicator of a fluid level in a non-pulmonary circulation of the patient;

causing the baroreflex therapy system to deliver a baroreflex therapy based at least in part on the indicator of a fluid level in a pulmonary circulation and the indicator of a fluid level in a non-pulmonary circulation, wherein the baroreflex therapy adjusts at least one of the fluid level in the pulmonary circulation and the fluid level in the non-pulmonary circulation.

8. The method of claim 7 , wherein monitoring an indicator of a fluid level in a non-pulmonary circulation of the patient comprises monitoring a splanchnic measurement representative of fluid status associated with a splanchnic organ.

9. The method of claim 7 , wherein causing the baroreflex therapy system to deliver a baroreflex therapy comprises delivering the baroreflex therapy in response to a decrease in the indicator of a fluid level in the non-pulmonary circulation of the patient below a specified threshold value.

10. The method of claim 7 , wherein causing the baroreflex therapy system to deliver a baroreflex therapy comprises delivering the baroreflex therapy in response to an increase in the indicator of a fluid level in the pulmonary circulation of the patient above a specified threshold value.

11. The method of claim 7 , wherein causing the baroreflex therapy system to deliver a baroreflex therapy comprises decreasing or ceasing the baroreflex therapy in response to at least one of:

a change in the indicator of a fluid level in the pulmonary circulation beyond a predetermined threshold value; or

a change in the indicator of a fluid level in the non-pulmonary circulation beyond a predetermined threshold value.

Assignments (2)
SECURITY INTEREST Recorded Oct 31, 2022
From: CVRX, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 061824/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2012
From: GEORGAKOPOULOS, DIMITRIOS; LOVETT, ERIC GRANT
To: CVRX, INC.
Reel/Frame 029151/0818 →
Continuity (4)
Division 13360339 · Jan 27, 2012
Division 12485895 · Jun 16, 2009
Provisional Application 61061938 · Jun 16, 2008
Related Publication 20130338735A1 · Dec 19, 2013